NA89
NOTICE OF ACCEPTANCE OF SEC. 8 & 9 - E-MAILED
10/31/2023
Back to search
Official data from USPTO
VIATREXX
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: WordOffice: United States
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
41
Latest update
10/31/2023
Trademark type
Word
Nice classes
5, 10
Filing date
09/19/2011
Registration date
06/18/2013
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
10/31/2023
Last transaction
10/31/2023
Responsible office
United States Patent and Trademark Office
Status code
800
Official register
Principal Register
Filing basis
Intent to use, Foreign priority
First use anywhere
10/16/2012
First use in commerce
10/16/2012
Drawing code
4
Owner type
01
Owner location
Newark, DE, CA
Examiner
HWANG, JOHN C B
Law office
M50
Current location
GENERIC WEB UPDATE
Holders and representatives
Holders
Emond, Stephen
Emond, Stephen
Representatives
Genevieve S. Larin
Technical classification
Nice Classes
Class 5Class 10
Vienna Codes
No Vienna codes available.
Goods and services
Class 5
VITAMINS; NUTRITIONAL SUPPLEMENTS; MINERAL NUTRITIONAL SUPPLEMENTS; HERBAL SUPPLEMENTS; HOMEOPATHIC SUPPLEMENTS; GLANDULAR EXTRACTS FOR TREATMENT OF GLANDULAR DEFICIENCIES; MEDICATED CHEWING GUM; PHARMACEUTICAL PREPARATIONS FOR THE TREATMENT OF PAINIMMUNE DISORDERSSKIN DISORDERSADIPOSITYCELLULITEVEIN DISORDERSDENTAL DISORDERSNEUROLOGICAL DISORDERSALLERGIES; PHARMACEUTICAL PREPARATIONS USED IN CONNECTION WITH BREAST AESTHETICFACIAL AESTHETICSKIN AESTHETIC; STERILE PHARMACEUTICAL SOLUTIONS FOR TREATMENT OF PAINIMMUNE DISORDERSSKIN DISORDERSADIPOSITYCELLULITEVEIN DISORDERSDENTAL DISORDERSNEUROLOGICAL DISORDERSALLERGIES; PREFILLED SYRINGES CONTAINING PHARMACEUTICAL PREPARATIONS FOR THE TREATMENT OF PAINIMMUNE DISORDERSSKIN DISORDERSADIPOSITYCELLULITEVEIN DISORDERSDENTAL DISORDERSNEUROLOGICAL DISORDERSALLERGIES; TRANSDERMAL PATCHES FOR USE IN THE TREATMENT OF PAINIMMUNE DISORDERSSKIN DISORDERSADIPOSITYCELLULITEVEIN DISORDERSDENTAL DISORDERSNEUROLOGICAL DISORDERSALLERGIES
Class 10
MEDICAL DEVICESTHERAPEUTIC INFRA-RED DEVICESBIOFEEDBACK DEVICES AND BIORESONANCE DEVICES THAT GENERATE OR READ MICROCURRENTSELECTRO-MAGNETIC IMPULSESBIOPHOTONS AND BIO-ENERGY INFORMATION FOR ANALYSIS AND THERAPEUTIC USE AND FOR DE-STRESSING AND WELLNESS ENHANCEMENT
Publications
History of USPTO decisions and trademark events.
41 publications found
RNL1
REGISTERED AND RENEWED (FIRST RENEWAL - 10 YRS)
10/31/2023
89AG
REGISTERED - SEC. 8 (10-YR) ACCEPTED/SEC. 9 GRANTED
10/31/2023
APRE
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
10/31/2023
E89R
TEAS SECTION 8 & 9 RECEIVED
05/05/2023
REM2
COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED
06/18/2022
NA85
NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED
06/28/2018
C15A
REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.
06/28/2018
APRE
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
06/28/2018
E815
TEAS SECTION 8 & 15 RECEIVED
06/18/2018
TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
06/18/2018
REM1
COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
06/18/2018
R.PR
REGISTERED-PRINCIPAL REGISTER
06/18/2013
SUNA
NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
05/16/2013
REGV
LAW OFFICE REGISTRATION REVIEW COMPLETED
05/15/2013
CNPR
ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
05/10/2013
SUPC
STATEMENT OF USE PROCESSING COMPLETE
05/10/2013
AITU
CASE ASSIGNED TO INTENT TO USE PARALEGAL
05/10/2013
IUAF
USE AMENDMENT FILED
04/22/2013
EISU
TEAS STATEMENT OF USE RECEIVED
04/22/2013
NOAM
NOA E-MAILED - SOU REQUIRED FROM APPLICANT
11/06/2012
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
09/11/2012
PUBO
PUBLISHED FOR OPPOSITION
09/11/2012
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
08/22/2012
PREV
LAW OFFICE PUBLICATION REVIEW COMPLETED
08/03/2012
ALIE
ASSIGNED TO LIE
08/01/2012
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
07/18/2012
XAEC
EXAMINER'S AMENDMENT ENTERED
07/18/2012
GNEN
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
07/18/2012
GNEA
EXAMINERS AMENDMENT E-MAILED
07/18/2012
CNEA
EXAMINERS AMENDMENT -WRITTEN
07/18/2012
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
06/21/2012
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
06/20/2012
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
06/20/2012
GNRN
NOTIFICATION OF NON-FINAL ACTION E-MAILED
01/09/2012
GNRT
NON-FINAL ACTION E-MAILED
01/09/2012
CNRT
NON-FINAL ACTION WRITTEN
01/09/2012
DOCK
ASSIGNED TO EXAMINER
01/05/2012
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
10/12/2011
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
10/12/2011
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
09/22/2011
Continuous trademark protection
Get notified about every new filing that threatens VIATREXX or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.